SIRT1 and diabetic kidney disease: Some studies have shown that Sirt1 is closely associated with the pathogenesis of diabetic nephropathy and represents a new potential therapeutic target for diabetic nephropathy (Munehiro et al., 2013; Sun et al., 2018).